MY146112A
(en )
2012-06-29
Long-term feed - cancer patient
MX361467B
(en )
2018-12-06
Isoindoline compounds for use in the treatment of cancer.
MX343135B
(en )
2016-10-25
Fumagillol type compounds and methods of making and using same.
PH12012501782A1
(en )
2012-11-12
Phytocannabinoids in the treatment of cancer
WO2010019271A8
(en )
2011-03-31
Fluorescent regulators of rassf1a expression and human cancer cell proliferation
MX2009008510A
(en )
2010-01-15
Activin-actriia antagonists and uses for promoting bone growth in cancer patients.
GB0700560D0
(en )
2007-02-21
Device and method for the treatment of diseased tissue such as tumours
TN2012000170A1
(en )
2013-12-12
Compositions for treating centrally mediated nausea and vomiting
EA201171367A1
(en )
2012-04-30
VINYLINDASOLYL COMPOUNDS
TR200906131T1
(en )
2009-11-23
Activin-actrIIa antagonists and treatment of breast cancer
MX2015007185A
(en )
2017-09-05
Use of eribulin in the treatment of breast cancer.
EP2046973A4
(en )
2010-04-07
For the identification, assessment, and treatment of patients with cancer therapy
MX2014011134A
(en )
2014-12-10
Carbamate compounds and of making and using same.
MX2011007930A
(en )
2011-09-06
Crystalline insulin-conjugates.
CR20120202A
(en )
2012-06-12
METHODS AND COMPOSITIONS TO TREAT CANCER
WO2010083385A3
(en )
2010-12-02
Compounds for reducing drug resistance and uses thereof
JO3635B1
(en )
2020-08-27
Solid pharmaceutical compositions and processes for their production
MX356755B
(en )
2018-06-11
Fumigillol type compounds and methods of making and using same.
IL207310A0
(en )
2010-12-30
Vaccine compositions
PH12015501088A1
(en )
2015-08-03
Dimeric compounds
MX2008015775A
(en )
2009-04-17
Compounds and compositions for treatment of cancer.
WO2008060945A3
(en )
2008-12-04
Diagnosis and treatment of breast cancer
WO2011056566A3
(en )
2011-06-30
Compounds and methods for treatment of cancer
WO2011163512A3
(en )
2013-04-25
Cancer therapy
AU2010298020A8
(en )
2013-10-10
Combination